ABOUT
- EGA
- Privacy Notice
- Security
- Team
- Bibliography
- Growth
- Community
- Archive
- Distribution
- Catalogue
- Projects
- Funders
- GA4GH
- Federated EGA
- Beacon
DISCOVERY
- Studies
- Datasets
- DACs
- Synthetic Data
- Search Box
- Public Metadata API
SUBMISSION
- File preparation
- Uploading files
- EGA Schema
- Sequencing & Phenotype
  - Submitter Portal
  - Submitter Portal API
- Array
- Programmatic Submission XML
ACCESS
- What is a DAC?
- Best Practices
- DAC Portal
- Data Use Conditions
- How to request data?
- Quality Control Reports
- Metadata
- Files
  - PyEGA3
  - Live Outbox
- Visualisation
  - FUSE Client
  - EGA QuickView

Tips on how to search

13304 results for ""pdc"+"heritage+language"+census+study"

in 11.41 milliseconds.

Filters

Filters

General Study Dataset

Type

blog dac dataset documentation study

Repository

dbgap ega jga

Federated ega

fegademo finland norway poland spain sweden

Study type

affected sib pairs aggregate genomic data amplicon sequencing atac sequencing cancer genomics case set case-cohort case-control clinical cohort clinical diagnostic testing clinical genetic testing clinical trial cohort collection community control set controlled trial copy number variation (cnv) cross-sectional double-blind electronic medical records epigenetics eqtl exome sequencing extended pedigrees family family linkage forensic or paleo-genomics full transcriptome sequencing gene regulation study genotype genotype/expression genotype/expression array gwas individual-level genomic data interventional longitudinal longitudinal cohort marker discovery mendelian meta-analysis metagenomics metastasis methods development mixed multicenter multiplex families nested case-control nuclear families observational other parent-offspring parent-offspring trios partial factorial randomized phase iii placebo-controlled pooled clone sequencing population population genomics population-based control set probands prospective quantitative cross-sectional randomized randomized controlled clinical trial reference set resequencing rna sequencing rnaseq sequencing sibling cohort single cell analysis single cell rna sequence single cell rna sequencing single patient snp array analysis stem cell lines synthetic genomics targeted capture sequence transcriptome analysis transcriptome sequencing transcriptome sequencing (tumor only) tumor tumor vs. matched-normal twin virus capture sequencing whole genome sequencing whole-genome bisulfite sequencing xenograft

Dataset types

amplicon sequencing chip-seq chromatin accessibility profiling by high-throughput sequencing exome sequencing genomic variant calling genotyping by array histone modification profiling by high-throughput sequencing methylation binding domain sequencing methylation profiling by high-throughput sequencing phenotype information study summary information transcriptome profiling by array transcriptome profiling by high-throughput sequencing whole genome sequencing

Dataset technologies

ab 3730xl genetic analyzer ab 5500xl genetic analyzer ab solid 4 system affy mirna 3.0 array affymetrics axiom snp array 2.0 affymetrix affymetrix 6.0 array affymetrix 6.0; cytoscan affymetrix axiom genome-wide asi 1 array affymetrix axiom genome-wide human origins array affymetrix biobank array affymetrix oncoscan ffpe express affymetrix, thermo fisher scientific agilent human mirna microarray axiom uk biobank array bgiseq-500 clariomâ„¢ d human assay complete genomics coreexome illumina snp chip array dnbseq-g400 dnbseq-t7 epic beadchip hiseq x five hiseq x ten human cardio metabochip human clariom d arrays human genome u219 array plate humanht-12 illumina (epic array) illumina 450k illumina cardio-metabochip illumina genome analyzer illumina genome analyzer ii illumina genome analyzer iix illumina global screening array illumina gsa v1.0 illumina hiseq 1000 illumina hiseq 1500 illumina hiseq 2000 illumina hiseq 2500 illumina hiseq 3000 illumina hiseq 4000 illumina hiseq x illumina human omni1-quad beadchip. illumina humancoreexome beadchip array illumina humancoreexome-12v1-1_a illumina humancoreexome-24v1-0 illumina humancoreexome-24v1-1 illumina humanmethylation450 illumina humanomni1-quad_v1-0 illumina humanomni1-quad_v1-0, humanomniexpress-12-v1-0, humanomniexpress-24-v1-1, humanomni25-8v1-2_a1 illumina humanomni2.5 illumina humanomni2.5-8 illumina humanomni5-quad and exome sequencing illumina humanomniexpress-12 illumina humanomniexpress-12-v1-0 illumina humanomniexpress-24-v1-1 illumina humanwg-6 illumina humanwg-6 version 3 or illumina humanht-12 expression bead chip, combined on identical nucleotide universal identifiers. illumina infinium epic illumina infinium h3africa (v2) with custom add-ons illumina infinium immunochip illumina infiniumomniexpressexome-8 illumina mega array illumina methylationepic v2.0 illumina miniseq illumina miseq illumina novaseq 6000 illumina novaseq x illumina novaseq x plus illumina omni 2.5 illumina omni 2.5m illumina oncoarray illumina sangerddd_omniexplusv1_15019773 infinium gsa infinium methylationepic array ion genestudio s5 ion torrent pgm ion torrent proton ion torrent s5 xl llumina 2.5-8 minion nextseq 2000 nextseq 500 nextseq 550 nimblegen hg18 cgh 385k omniexpress omniexpress-24 v1.1 pacbio rs ii promethion qexactive plus sanger sequencing sequel sequel ii sequel iie sequenom massarray (agena bioscience) somascan 1.3k proteomic assay uk biobank axiomâ„¢ array unspecified

Phenotypes

CHEBI:33699 CL:0000037 CL:0000084 CL:0000094 CL:0000235 CL:0000576 CL:0000837 CL:0000863 CL:0000890 CL:0002057 EFO:0000094 EFO:0000209 EFO:0000211 EFO:0000220 EFO:0000222 EFO:0000272 EFO:0000275 EFO:0000280 EFO:0000285 EFO:0000309 EFO:0000322 EFO:0000330 EFO:0000339 EFO:0000349 EFO:0000403 EFO:0000478 EFO:0000519 EFO:0000565 EFO:0000574 EFO:0000586 EFO:0000609 EFO:0000632 EFO:0000637 EFO:0000693 EFO:0000980 EFO:0001461 EFO:0001663 EFO:0001905 EFO:0002001 EFO:0002002 EFO:0002422 EFO:0002499 EFO:0002508 EFO:0002539 EFO:0002759 EFO:0002939 EFO:0002966 EFO:0003025 EFO:0003094 EFO:0003885 EFO:0003897 EFO:0003940 EFO:0004281 EFO:0005023 EFO:0005543 EFO:0005699 EFO:0005704 EFO:0005705 EFO:0005706 EFO:0005707 EFO:0005708 EFO:0005709 EFO:0005710 EFO:0005711 EFO:0005712 EFO:0005740 EFO:0005922 EFO:0006545 EFO:0009119 EFO:0009121 EFO:0009443 EFO:0010064 EFO:1000028 EFO:1000042 EFO:1000068 EFO:1000069 EFO:1000177 EFO:1000180 EFO:1000231 EFO:1000238 EFO:1000327 EFO:1000490 EFO:1001480 EFO:1001514 EFO:1001515 EFO:1001830 EFO:1001956 EFO:1001958 EFO:1002008 HP:0000001 HP:0000002 HP:0000008 HP:0000009 HP:0000010 HP:0000014 HP:0000020 HP:0000022 HP:0000023 HP:0000028 HP:0000032 HP:0000035 HP:0000036 HP:0000045 HP:0000047 HP:0000049 HP:0000062 HP:0000069 HP:0000073 HP:0000076 HP:0000077 HP:0000078 HP:0000079 HP:0000085 HP:0000086 HP:0000089 HP:0000098 HP:0000100 HP:0000104 HP:0000107 HP:0000110 HP:0000118 HP:0000119 HP:0000121 HP:0000125 HP:0000126 HP:0000137 HP:0000138 HP:0000152 HP:0000153 HP:0000154 HP:0000157 HP:0000159 HP:0000160 HP:0000161 HP:0000162 HP:0000163 HP:0000164 HP:0000168 HP:0000172 HP:0000174 HP:0000175 HP:0000176 HP:0000177 HP:0000178 HP:0000179 HP:0000185 HP:0000193 HP:0000202 HP:0000212 HP:0000215 HP:0000218 HP:0000219 HP:0000220 HP:0000233 HP:0000234 HP:0000235 HP:0000236 HP:0000238 HP:0000239 HP:0000240 HP:0000243 HP:0000248 HP:0000252 HP:0000253 HP:0000256 HP:0000260 HP:0000268 HP:0000270 HP:0000271 HP:0000276 HP:0000277 HP:0000278 HP:0000280 HP:0000284 HP:0000286 HP:0000288 HP:0000290 HP:0000294 HP:0000301 HP:0000303 HP:0000306 HP:0000307 HP:0000308 HP:0000309 HP:0000315 HP:0000316 HP:0000319 HP:0000324 HP:0000325 HP:0000326 HP:0000327 HP:0000337 HP:0000338 HP:0000340 HP:0000341 HP:0000343 HP:0000347 HP:0000356 HP:0000357 HP:0000358 HP:0000359 HP:0000363 HP:0000364 HP:0000365 HP:0000366 HP:0000368 HP:0000369 HP:0000370 HP:0000377 HP:0000378 HP:0000383 HP:0000384 HP:0000388 HP:0000396 HP:0000403 HP:0000405 HP:0000407 HP:0000412 HP:0000414 HP:0000422 HP:0000426 HP:0000429 HP:0000430 HP:0000431 HP:0000436 HP:0000444 HP:0000453 HP:0000455 HP:0000463 HP:0000464 HP:0000465 HP:0000470 HP:0000478 HP:0000479 HP:0000483 HP:0000486 HP:0000487 HP:0000490 HP:0000492 HP:0000494 HP:0000496 HP:0000498 HP:0000499 HP:0000501 HP:0000504 HP:0000505 HP:0000506 HP:0000508 HP:0000517 HP:0000518 HP:0000519 HP:0000520 HP:0000521 HP:0000525 HP:0000526 HP:0000527 HP:0000532 HP:0000534 HP:0000539 HP:0000540 HP:0000543 HP:0000545 HP:0000548 HP:0000549 HP:0000553 HP:0000556 HP:0000565 HP:0000568 HP:0000574 HP:0000577 HP:0000579 HP:0000581 HP:0000582 HP:0000587 HP:0000589 HP:0000591 HP:0000592 HP:0000593 HP:0000598 HP:0000599 HP:0000601 HP:0000606 HP:0000609 HP:0000610 HP:0000612 HP:0000614 HP:0000615 HP:0000635 HP:0000637 HP:0000639 HP:0000646 HP:0000648 HP:0000649 HP:0000657 HP:0000659 HP:0000664 HP:0000668 HP:0000670 HP:0000678 HP:0000680 HP:0000684 HP:0000687 HP:0000691 HP:0000692 HP:0000696 HP:0000699 HP:0000705 HP:0000707 HP:0000708 HP:0000716 HP:0000717 HP:0000718 HP:0000722 HP:0000723 HP:0000729 HP:0000736 HP:0000739 HP:0000750 HP:0000752 HP:0000753 HP:0000759 HP:0000762 HP:0000765 HP:0000766 HP:0000767 HP:0000769 HP:0000772 HP:0000774 HP:0000775 HP:0000776 HP:0000795 HP:0000800 HP:0000803 HP:0000807 HP:0000811 HP:0000812 HP:0000818 HP:0000820 HP:0000821 HP:0000822 HP:0000824 HP:0000826 HP:0000830 HP:0000864 HP:0000871 HP:0000924 HP:0000925 HP:0000927 HP:0000929 HP:0000940 HP:0000944 HP:0000951 HP:0000953 HP:0000954 HP:0000957 HP:0000958 HP:0000960 HP:0000964 HP:0000965 HP:0000969 HP:0000972 HP:0000973 HP:0000977 HP:0000978 HP:0000980 HP:0000998 HP:0001000 HP:0001007 HP:0001009 HP:0001010 HP:0001018 HP:0001022 HP:0001025 HP:0001027 HP:0001028 HP:0001029 HP:0001034 HP:0001048 HP:0001072 HP:0001098 HP:0001107 HP:0001118 HP:0001141 HP:0001147 HP:0001155 HP:0001156 HP:0001159 HP:0001161 HP:0001162 HP:0001167 HP:0001171 HP:0001172 HP:0001177 HP:0001178 HP:0001180 HP:0001182 HP:0001187 HP:0001191 HP:0001193 HP:0001194 HP:0001197 HP:0001211 HP:0001212 HP:0001218 HP:0001220 HP:0001249 HP:0001250 HP:0001251 HP:0001252 HP:0001254 HP:0001256 HP:0001257 HP:0001258 HP:0001263 HP:0001266 HP:0001270 HP:0001273 HP:0001274 HP:0001276 HP:0001285 HP:0001288 HP:0001290 HP:0001291 HP:0001297 HP:0001298 HP:0001305 HP:0001308 HP:0001311 HP:0001317 HP:0001319 HP:0001321 HP:0001324 HP:0001328 HP:0001332 HP:0001339 HP:0001342 HP:0001344 HP:0001347 HP:0001357 HP:0001362 HP:0001363 HP:0001367 HP:0001371 HP:0001373 HP:0001374 HP:0001380 HP:0001382 HP:0001384 HP:0001385 HP:0001392 HP:0001421 HP:0001435 HP:0001438 HP:0001446 HP:0001476 HP:0001488 HP:0001492 HP:0001507 HP:0001508 HP:0001510 HP:0001511 HP:0001513 HP:0001518 HP:0001519 HP:0001520 HP:0001528 HP:0001531 HP:0001537 HP:0001539 HP:0001545 HP:0001547 HP:0001548 HP:0001551 HP:0001555 HP:0001561 HP:0001562 HP:0001574 HP:0001582 HP:0001591 HP:0001595 HP:0001597 HP:0001598 HP:0001600 HP:0001601 HP:0001608 HP:0001609 HP:0001611 HP:0001612 HP:0001622 HP:0001623 HP:0001626 HP:0001627 HP:0001629 HP:0001631 HP:0001633 HP:0001634 HP:0001635 HP:0001636 HP:0001637 HP:0001638 HP:0001639 HP:0001641 HP:0001642 HP:0001643 HP:0001644 HP:0001646 HP:0001647 HP:0001649 HP:0001650 HP:0001651 HP:0001654 HP:0001655 HP:0001667 HP:0001671 HP:0001674 HP:0001679 HP:0001680 HP:0001684 HP:0001691 HP:0001692 HP:0001707 HP:0001710 HP:0001711 HP:0001713 HP:0001714 HP:0001719 HP:0001738 HP:0001757 HP:0001760 HP:0001762 HP:0001763 HP:0001769 HP:0001770 HP:0001772 HP:0001773 HP:0001776 HP:0001780 HP:0001790 HP:0001791 HP:0001792 HP:0001800 HP:0001814 HP:0001829 HP:0001830 HP:0001831 HP:0001832 HP:0001837 HP:0001838 HP:0001839 HP:0001841 HP:0001844 HP:0001850 HP:0001863 HP:0001864 HP:0001868 HP:0001871 HP:0001872 HP:0001873 HP:0001877 HP:0001878 HP:0001883 HP:0001892 HP:0001903 HP:0001920 HP:0001933 HP:0001939 HP:0001941 HP:0001943 HP:0001945 HP:0001954 HP:0001955 HP:0001956 HP:0001961 HP:0001965 HP:0001999 HP:0002002 HP:0002006 HP:0002007 HP:0002011 HP:0002012 HP:0002015 HP:0002017 HP:0002019 HP:0002020 HP:0002023 HP:0002025 HP:0002031 HP:0002032 HP:0002034 HP:0002037 HP:0002058 HP:0002059 HP:0002060 HP:0002061 HP:0002063 HP:0002070 HP:0002072 HP:0002073 HP:0002079 HP:0002086 HP:0002087 HP:0002088 HP:0002090 HP:0002092 HP:0002093 HP:0002094 HP:0002098 HP:0002099 HP:0002104 HP:0002109 HP:0002115 HP:0002118 HP:0002119 HP:0002121 HP:0002123 HP:0002126 HP:0002127 HP:0002132 HP:0002133 HP:0002134 HP:0002143 HP:0002148 HP:0002162 HP:0002164 HP:0002167 HP:0002170 HP:0002186 HP:0002187 HP:0002188 HP:0002194 HP:0002197 HP:0002202 HP:0002205 HP:0002208 HP:0002209 HP:0002212 HP:0002219 HP:0002232 HP:0002236 HP:0002240 HP:0002242 HP:0002247 HP:0002250 HP:0002251 HP:0002263 HP:0002265 HP:0002275 HP:0002281 HP:0002283 HP:0002286 HP:0002307 HP:0002308 HP:0002311 HP:0002315 HP:0002342 HP:0002352 HP:0002353 HP:0002360 HP:0002366 HP:0002370 HP:0002371 HP:0002373 HP:0002376 HP:0002394 HP:0002410 HP:0002414 HP:0002418 HP:0002421 HP:0002435 HP:0002438 HP:0002450 HP:0002453 HP:0002470 HP:0002475 HP:0002500 HP:0002507 HP:0002518 HP:0002539 HP:0002553 HP:0002557 HP:0002558 HP:0002564 HP:0002575 HP:0002577 HP:0002583 HP:0002589 HP:0002591 HP:0002597 HP:0002607 HP:0002633 HP:0002644 HP:0002645 HP:0002648 HP:0002650 HP:0002652 HP:0002664 HP:0002665 HP:0002683 HP:0002705 HP:0002715 HP:0002719 HP:0002721 HP:0002744 HP:0002748 HP:0002756 HP:0002757 HP:0002761 HP:0002763 HP:0002777 HP:0002778 HP:0002779 HP:0002780 HP:0002783 HP:0002788 HP:0002793 HP:0002795 HP:0002803 HP:0002804 HP:0002808 HP:0002813 HP:0002814 HP:0002815 HP:0002817 HP:0002818 HP:0002823 HP:0002825 HP:0002827 HP:0002857 HP:0002907 HP:0002921 HP:0002926 HP:0002937 HP:0002943 HP:0002944 HP:0002949 HP:0002967 HP:0002974 HP:0002977 HP:0002979 HP:0002981 HP:0002991 HP:0003011 HP:0003019 HP:0003026 HP:0003028 HP:0003038 HP:0003043 HP:0003072 HP:0003074 HP:0003111 HP:0003117 HP:0003121 HP:0003128 HP:0003186 HP:0003189 HP:0003196 HP:0003201 HP:0003202 HP:0003271 HP:0003272 HP:0003312 HP:0003316 HP:0003319 HP:0003330 HP:0003336 HP:0003366 HP:0003368 HP:0003393 HP:0003422 HP:0003468 HP:0003498 HP:0003502 HP:0003508 HP:0003510 HP:0003549 HP:0003693 HP:0003763 HP:0003781 HP:0003808 HP:0003839 HP:0004050 HP:0004097 HP:0004099 HP:0004207 HP:0004209 HP:0004233 HP:0004275 HP:0004279 HP:0004297 HP:0004298 HP:0004299 HP:0004305 HP:0004322 HP:0004323 HP:0004324 HP:0004325 HP:0004328 HP:0004329 HP:0004348 HP:0004349 HP:0004360 HP:0004363 HP:0004370 HP:0004372 HP:0004375 HP:0004378 HP:0004383 HP:0004384 HP:0004386 HP:0004387 HP:0004397 HP:0004404 HP:0004414 HP:0004425 HP:0004442 HP:0004467 HP:0004470 HP:0004474 HP:0004488 HP:0004626 HP:0004691 HP:0004692 HP:0004749 HP:0004755 HP:0004768 HP:0004789 HP:0004798 HP:0004814 HP:0004881 HP:0004885 HP:0004890 HP:0004912 HP:0004930 HP:0004960 HP:0004971 HP:0004991 HP:0005101 HP:0005105 HP:0005107 HP:0005110 HP:0005111 HP:0005114 HP:0005115 HP:0005120 HP:0005133 HP:0005160 HP:0005176 HP:0005233 HP:0005257 HP:0005258 HP:0005264 HP:0005280 HP:0005288 HP:0005301 HP:0005323 HP:0005345 HP:0005425 HP:0005462 HP:0005484 HP:0005487 HP:0005490 HP:0005556 HP:0005599 HP:0005605 HP:0005607 HP:0005616 HP:0005620 HP:0005651 HP:0005656 HP:0005684 HP:0005692 HP:0005701 HP:0005709 HP:0005750 HP:0005781 HP:0005815 HP:0005850 HP:0005876 HP:0005912 HP:0005918 HP:0005920 HP:0005924 HP:0005927 HP:0005930 HP:0005949 HP:0005957 HP:0005968 HP:0005988 HP:0006108 HP:0006210 HP:0006257 HP:0006261 HP:0006265 HP:0006292 HP:0006335 HP:0006347 HP:0006380 HP:0006466 HP:0006481 HP:0006482 HP:0006483 HP:0006487 HP:0006492 HP:0006493 HP:0006494 HP:0006495 HP:0006496 HP:0006504 HP:0006505 HP:0006532 HP:0006536 HP:0006541 HP:0006563 HP:0006579 HP:0006665 HP:0006703 HP:0006704 HP:0006705 HP:0006709 HP:0006772 HP:0006801 HP:0006818 HP:0006824 HP:0006829 HP:0006862 HP:0006870 HP:0006887 HP:0006927 HP:0006934 HP:0006970 HP:0007018 HP:0007053 HP:0007064 HP:0007095 HP:0007099 HP:0007105 HP:0007109 HP:0007149 HP:0007165 HP:0007256 HP:0007319 HP:0007330 HP:0007359 HP:0007364 HP:0007367 HP:0007370 HP:0007379 HP:0007385 HP:0007400 HP:0007413 HP:0007441 HP:0007477 HP:0007513 HP:0007543 HP:0007565 HP:0007598 HP:0007633 HP:0007678 HP:0007700 HP:0007730 HP:0007744 HP:0007754 HP:0007758 HP:0007858 HP:0007898 HP:0007911 HP:0007917 HP:0007930 HP:0007933 HP:0007946 HP:0007970 HP:0007971 HP:0008002 HP:0008012 HP:0008034 HP:0008050 HP:0008051 HP:0008056 HP:0008067 HP:0008069 HP:0008070 HP:0008075 HP:0008209 HP:0008244 HP:0008365 HP:0008373 HP:0008386 HP:0008388 HP:0008404 HP:0008414 HP:0008439 HP:0008491 HP:0008504 HP:0008519 HP:0008527 HP:0008544 HP:0008551 HP:0008572 HP:0008591 HP:0008619 HP:0008678 HP:0008696 HP:0008770 HP:0008771 HP:0008772 HP:0008776 HP:0008846 HP:0008848 HP:0008850 HP:0008872 HP:0008873 HP:0008883 HP:0008905 HP:0008935 HP:0008936 HP:0008942 HP:0008947 HP:0008954 HP:0009003 HP:0009062 HP:0009110 HP:0009115 HP:0009116 HP:0009117 HP:0009118 HP:0009121 HP:0009122 HP:0009123 HP:0009127 HP:0009129 HP:0009130 HP:0009142 HP:0009144 HP:0009179 HP:0009380 HP:0009381 HP:0009466 HP:0009473 HP:0009484 HP:0009485 HP:0009553 HP:0009600 HP:0009601 HP:0009602 HP:0009603 HP:0009617 HP:0009623 HP:0009641 HP:0009719 HP:0009726 HP:0009733 HP:0009765 HP:0009767 HP:0009774 HP:0009775 HP:0009778 HP:0009796 HP:0009804 HP:0009810 HP:0009811 HP:0009813 HP:0009815 HP:0009826 HP:0009830 HP:0009832 HP:0009835 HP:0009887 HP:0009889 HP:0009890 HP:0009891 HP:0009895 HP:0009896 HP:0009899 HP:0009909 HP:0009918 HP:0009921 HP:0009924 HP:0009929 HP:0009937 HP:0009997 HP:0010055 HP:0010057 HP:0010066 HP:0010100 HP:0010161 HP:0010181 HP:0010230 HP:0010243 HP:0010281 HP:0010290 HP:0010292 HP:0010301 HP:0010438 HP:0010442 HP:0010460 HP:0010461 HP:0010465 HP:0010490 HP:0010491 HP:0010508 HP:0010511 HP:0010518 HP:0010522 HP:0010529 HP:0010535 HP:0010549 HP:0010550 HP:0010551 HP:0010566 HP:0010576 HP:0010579 HP:0010621 HP:0010624 HP:0010627 HP:0010628 HP:0010636 HP:0010647 HP:0010651 HP:0010660 HP:0010674 HP:0010692 HP:0010720 HP:0010758 HP:0010759 HP:0010767 HP:0010781 HP:0010783 HP:0010786 HP:0010808 HP:0010827 HP:0010862 HP:0010864 HP:0010866 HP:0010876 HP:0010927 HP:0010929 HP:0010935 HP:0010936 HP:0010938 HP:0010944 HP:0010946 HP:0010978 HP:0010993 HP:0011003 HP:0011004 HP:0011013 HP:0011014 HP:0011015 HP:0011024 HP:0011025 HP:0011028 HP:0011029 HP:0011032 HP:0011035 HP:0011039 HP:0011061 HP:0011098 HP:0011119 HP:0011121 HP:0011122 HP:0011123 HP:0011138 HP:0011218 HP:0011220 HP:0011228 HP:0011231 HP:0011250 HP:0011276 HP:0011282 HP:0011283 HP:0011297 HP:0011298 HP:0011314 HP:0011328 HP:0011329 HP:0011335 HP:0011337 HP:0011339 HP:0011342 HP:0011354 HP:0011355 HP:0011356 HP:0011357 HP:0011358 HP:0011361 HP:0011362 HP:0011389 HP:0011398 HP:0011409 HP:0011442 HP:0011443 HP:0011446 HP:0011451 HP:0011458 HP:0011466 HP:0011470 HP:0011471 HP:0011476 HP:0011481 HP:0011603 HP:0011641 HP:0011675 HP:0011723 HP:0011729 HP:0011747 HP:0011772 HP:0011792 HP:0011793 HP:0011799 HP:0011804 HP:0011805 HP:0011821 HP:0011833 HP:0011842 HP:0011843 HP:0011844 HP:0011849 HP:0011873 HP:0011895 HP:0011927 HP:0011937 HP:0011947 HP:0011968 HP:0011973 HP:0011994 HP:0012031 HP:0012032 HP:0012106 HP:0012116 HP:0012165 HP:0012210 HP:0012243 HP:0012252 HP:0012303 HP:0012304 HP:0012371 HP:0012372 HP:0012373 HP:0012374 HP:0012385 HP:0012443 HP:0012444 HP:0012503 HP:0012531 HP:0012638 HP:0012639 HP:0012700 HP:0012718 HP:0012719 HP:0012725 HP:0012732 HP:0012736 HP:0012757 HP:0012758 HP:0012759 HP:0012785 HP:0012795 HP:0030084 HP:0100006 HP:0100022 HP:0100033 HP:0100037 HP:0100038 HP:0100255 HP:0100257 HP:0100276 HP:0100277 HP:0100282 HP:0100309 HP:0100326 HP:0100335 HP:0100360 HP:0100490 HP:0100491 HP:0100529 HP:0100533 HP:0100538 HP:0100542 HP:0100543 HP:0100545 HP:0100547 HP:0100555 HP:0100556 HP:0100559 HP:0100594 HP:0100627 HP:0100656 HP:0100659 HP:0100660 HP:0100665 HP:0100704 HP:0100705 HP:0100736 HP:0100737 HP:0100738 HP:0100742 HP:0100746 HP:0100755 HP:0100763 HP:0100764 HP:0100790 HP:0100806 HP:0100807 HP:0100817 HP:0100836 HP:0100851 HP:0100852 HP:0100871 HP:0100876 HP:0100886 HP:0100887 HP:0200006 HP:0200007 HP:0200013 HP:0200021 HP:0200053 HP:0200055 MONDO:0002598 MONDO:0002627 MONDO:0002631 MONDO:0002728 MONDO:0003478 MONDO:0003537 MONDO:0004050 MONDO:0004301 MONDO:0005072 MONDO:0013296 MONDO:0016642 MONDO:0016690 MONDO:0016691 MONDO:0016700 MONDO:0018177 MONDO:0019470 MONDO:0019474 MONDO:0020511 MONDO:0020560 MONDO:0100096 MONDO:0100342 NCIT:C200033 NCIT:C3099 NCIT:C3468 NCIT:C4737 NCIT:C4873 Orphanet:3095 Orphanet:98892 PATO:0000461 UBERON:0013756

Duo

0000001 0000004 0000005 0000006 0000007 0000011 0000012 0000014 0000015 0000016 0000017 0000018 0000019 0000020 0000021 0000022 0000024 0000025 0000026 0000027 0000028 0000029 0000042 0000043 0000044 0000045 0000046

Clear

Slim Initiative in Genomic Medicine for the Americas (SIGMA): Diabetes in Mexico Study (DMS)

The ~52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2 diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) Genetics of Type 2 Diabetes (GoT2D) Exome Sequencing Project (ESP) Slim Initiative in Genomic Medicine for the Americas: Type 2 Diabetes (SIGMA T2D) Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (LuCAMP) Progress in Diabetes Genetics in Youth (ProDIGY) This data generated from the SIGMA Diabetes in Mexico Study (DMS) was part of the Slim Initiative in Genomic Medicine for the Americas: Type 2 Diabetes (SIGMA T2D), which is an international research consortium funded by the Carlos Slim Foundation that seeks to identify the genetic risk factors for type 2 diabetes (T2D) in Mexico and Latin America and translate those findings into improved treatment and prevention of diabetes. The SIGMA T2D project has sequenced and genotyped more than 13,000 samples from Mexican and Mexican Americans. The individuals were obtained from over 20 cohorts across the 6 consortia that are listed in Table 1. The strategy was to perform deep exome sequencing of individuals, 24,991 with T2D and 24,953 controls, divided among five ancestry groups: Europeans, East Asians, South Asians, American Hispanics, and African Americans. The T2D-GENES, ProDIGY and SIGMA studies, sequencing was performed at the Broad Institute using the Agilent v2 capture reagent or Illumina Rapid Capture on Illumina HiSeq machines. Please note that while we summarize the full sample list in publications and below, two of the cohorts below are not in dbGaP, due to the samples not being consented for deposition. This includes the Kooperative Gesundheitsforschung in der Region Augsburg (KORA) study and Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (LuCamp) study. The Exome Sequencing Project (ESP) was deposited in dbGaP as part of their initial study and the phs numbers for that project can be found here: https://esp.gs.washington.edu/drupal/dbGaP_Releases. Table 1. 52,000 sample T2D Case/Control Whole Exome Sequencing Studies Ancestry Consortia Study Countries of Origin # Cases # Controls African American T2D-GENES Project 1 Jackson Heart Study US 500 526 African American T2D-GENES Project 1 Wake Forest School of Medicine Study US 518 530 African American ESP Exome Sequencing Project (ESP) US 467 1374 African American T2D-GENES Follow up study BioMe Biobank Program (BioMe) US 1297 1256 East Asian T2D-GENES Project 1 Korea Association Research Project Korea 526 561 East Asian T2D-GENES Project 1& Follow up Study Singapore Diabetes Cohort Study; Singapore Prospective Study Program Singapore (Chinese) 1486 1568 East Asian T2D-GENES Follow up study Korea SNUH South Korea 450 475 East Asian T2D-GENES Follow up study Research Studies in Hong Kong (Hong Kong) Hong Kong 493 485 European T2D-GENES Project 1 Ashkenazi US, Israel 506 355 European T2D-GENES Project 1 Metabolic Syndrome in Men Study (METSIM) Finland 484 498 European GoT2D Finland-United States Investigation of NIDDM Genetics (FUSION) Study Finland 472 476 European GoT2D Kooperative Gesundheitsforschung in der Region Augsburg (KORA) Germany 97 90 European GoT2D UK Type 2 Diabetes Genetics Consortium (UKT2D) UK 322 320 European GoT2D Malmo-Botnia Study Finland, Sweden 478 443 European LuCamp Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (LuCamp) Denmark 997 997 European ESP Exome Sequencing Project (ESP) US 390 2843 European T2D-GENES Follow up study Genetics of Diabetes and Audit Research Tayside Study (GoDARTS) Scotland, UK 960 966 European T2D-GENES Follow up study Framingham Heart Study (FHS) US 396 596 Hispanic T2D-GENES Project 1 San Antonio Family Heart Study, San Antonio Family Diabetes/ Gallbladder Study, Veterans Administration Genetic Epidemiology Study, and the Investigation of Nephropathy and Diabetes Study Family Component US 272 218 Hispanic T2D-GENES Project 1 & SIGMAv2 Starr County, Texas US 1762 1738 Hispanic SIGMAv1 Mexico City Diabetes Study Mexico 281 549 Hispanic SIGMAv1 & v2 Multiethnic Cohort (MEC) US 1476 1443 Hispanic SIGMAv1 & v2 UNAM/INCMNSZ Diabetes Study (UIDS) Mexico 1998 1977 Hispanic SIGMAv1 & v2 Diabetes in Mexico Study (DMS) Mexico 1522 1546 Multi ethnic ProDIGY Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) US 3097 0 Multi ethnic ProDIGY SEARCH for Diabetes in Youth (SEARCH) US 553 0 South Asian T2D-GENES Project 1 London Life Sciences Population Study (LOLIPOP) UK (Indian Asian) 531 538 South Asian T2D-GENES Project 1 & Follow up study Singapore Indian Eye Study Singapore (Indian Asian) 1640 1478 South Asian T2D-GENES Follow up study Pakistan Genomic Resource (PGR) Pakistan 914 932 The Diabetes in Mexico Study (DMS) study contributed 1,522 cases and 1,546 controls to the 52k T2D exome sequencing study.
Study phs001388
Study of non-clear cell renal cell carcinoma

Study of non-clear cell renal cell carcinoma
Study EGAS00001000926
Shanghai Breast Cancer Genetics Study (SBCGS)

The Shanghai Breast Cancer Genetics Study (SBCGS) includes data from four population-based studies conducted among Chinese women in urban Shanghai: the Shanghai Breast Cancer Study (SBCS), the Shanghai Breast Cancer Survival Study (SBCSS), the Shanghai Women's Health Study (SWHS), and the Shanghai Endometrial Cancer Study (SECS, contributing controls only). Shanghai Breast Cancer Study (SBCS): The SBCS is a population-based, case-control study conducted in urban Shanghai. Subject recruitment in the initial phase of the SBCS (SBCS-I) was conducted between August 1996 and March 1998. The second phase (SBCS-II) of recruitment occurred between April 2002 and February 2005. Breast cancer cases were identified through the population-based Shanghai Cancer Registry and supplemented by a rapid case-ascertainment system. Controls were randomly selected using the Shanghai Resident Registry. Approximately 3500 cases and 3500 controls were recruited in the study. Shanghai Breast Cancer Survival Study (SBCSS) and Shanghai Endometrial Cancer Study (SECS): The SBCSS also used the population-based Shanghai Cancer Registry to identify newly diagnosed breast cancer cases. A total of 5,046 breast cancer patients were recruited. In-person interviews were conducted to collect information on known breast cancer risk factors and anthropometrics by using protocols and questionnaires similar to those used in the SBCS. For genetic studies, controls for the SBCSS cases came from the SECS, which recruited healthy women between January 1997 and December 2003. With the exception of a few questions related specifically to breast or endometrial cancer risk, the questionnaires used in the SECS and the SBCS were very similar. Shanghai Women's Health Study (SWHS): The SWHS is a population-based prospective cohort study of approximately 75,000 adult women who were recruited between 1997 and 2000. The cohort has been followed by a combination of record linkage and active follow-ups. Breast cancer patients identified in the SWHS and non-cases were included in the current study.
Study phs001088
Shanghai Breast Cancer Genetics Study (SBCGS)

The Shanghai Breast Cancer Genetics Study (SBCGS) includes data from four population-based studies conducted among Chinese women in urban Shanghai: the Shanghai Breast Cancer Study (SBCS), the Shanghai Breast Cancer Survival Study (SBCSS), the Shanghai Women's Health Study (SWHS), and the Shanghai Endometrial Cancer Study (SECS, contributing controls only). Shanghai Breast Cancer Study (SBCS): The SBCS is a population-based, case-control study conducted in urban Shanghai. Subject recruitment in the initial phase of the SBCS (SBCS-I) was conducted between August 1996 and March 1998. The second phase (SBCS-II) of recruitment occurred between April 2002 and February 2005. Breast cancer cases were identified through the population-based Shanghai Cancer Registry and supplemented by a rapid case-ascertainment system. Controls were randomly selected using the Shanghai Resident Registry. Approximately 3500 cases and 3500 controls were recruited in the study. Shanghai Breast Cancer Survival Study (SBCSS) and Shanghai Endometrial Cancer Study (SECS): The SBCSS also used the population-based Shanghai Cancer Registry to identify newly diagnosed breast cancer cases. A total of 5,046 breast cancer patients were recruited. In-person interviews were conducted to collect information on known breast cancer risk factors and anthropometrics by using a protocol and questionnaire similar to those used in the SBCS. For genetic studies, controls for the SBCSS cases came from the SECS, which recruited healthy women between January 1997 and December 2003. With the exception of a few questions related specifically to breast or endometrial cancer risk, the questionnaires used in the SECS and the SBCS were very similar. Shanghai Women's Health Study (SWHS): The SWHS is a population-based prospective cohort study of approximately 75,000 adult women who were recruited between 1997 and 2000. The cohort has been followed by a combination of record linkage and active follow-ups. Breast cancer patients identified in the SWHS and non-cases were included in the current study.
Study phs000799
WTCCC case-control study for Multiple Sclerosis - Combined controls

WTCCC genome-wide accosication study for Multiple Sclerosis (MS) - Combined controls
Study EGAS00000000023
RNA sequencing study for 8 pairs of primary NSCLCs and distant metastases

This study is to understand of the molecular mechanisms driving metastasis.
Study EGAS00001004078
Whole exome sequencing study for 8 pairs of primary NSCLCs and distant metastases

This study is to understand of the molecular mechanisms driving metastasis.
Study EGAS00001004077
Progress in Diabetes Genetics in Youth (ProDIGY) Exome Sequencing Study: SEARCH for Diabetes in Youth

The ~52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2 diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) Genetics of Type 2 Diabetes (GoT2D) Exome Sequencing Project (ESP) Slim Initiative in Genomic Medicine for the Americas (SIGMA) Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (LuCAMP) Progress in Diabetes Genetics in Youth (ProDIGY) This data generated from the SEARCH for Diabetes in Youth cohort was part of the ProDIGY (Progress in Diabetes Genetics in Youth) consortium, which is a NIDDK-funded research consortium that investigated genetic variants for childhood type 2 diabetes (T2D). This consortium involved sequencing multiethnic samples from childhood T2D cases located across the United States. The individuals were obtained from over 20 cohorts across the 6 consortia that are listed in Table 1. The strategy was to perform deep exome sequencing of individuals, 24,991 with T2D and 24,953 controls, divided among five ancestry groups: Europeans, East Asians, South Asians, American Hispanics, and African Americans. The T2D-GENES, ProDIGY and SIGMA studies, sequencing was performed at the Broad Institute using the Agilent v2 capture reagent or Illumina Rapid Capture on Illumina HiSeq machines. Please note that while we summarize the full sample list in publications and below, two of the cohorts below are not in dbGAP, due to the samples not being consented for deposition. This includes the Kooperative Gesundheitsforschung in der Region Augsburg (KORA) study and Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (LuCamp) study. The Exome Sequencing Project (ESP) was deposited in dbGAP as part of their initial study and the phs numbers for that project can be found here: https://esp.gs.washington.edu/drupal/dbGaP_Releases. Table 1. 52,000 sample T2D Case/Control Whole Exome Sequencing Studies table, th, td { border: 1px solid black; border-collapse: collapse; } Ancestry Consortia Study Countries of Origin # Cases # Controls African American T2D-GENES Project 1 Jackson Heart Study US 500 526 African American T2D-GENES Project 1 Wake Forest School of Medicine Study US 518 530 African American ESP Exome Sequencing Project (ESP) US 467 1374 African American T2D-GENES Follow up study BioMe Biobank Program (BioMe) US 1297 1256 East Asian T2D-GENES Project 1 Korea Association Research Project Korea 526 561 East Asian T2D-GENES Project 1& Follow up Study Singapore Diabetes Cohort Study; Singapore Prospective Study Program Singapore (Chinese) 1486 1568 East Asian T2D-GENES Follow up study Korea SNUH South Korea 450 475 East Asian T2D-GENES Follow up study Research Studies in Hong Kong (Hong Kong) Hong Kong 493 485 European T2D-GENES Project 1 Ashkenazi US, Israel 506 355 European T2D-GENES Project 1 Metabolic Syndrome in Men Study (METSIM) Finland 484 498 European GoT2D Finland-United States Investigation of NIDDM Genetics (FUSION) Study Finland 472 476 European GoT2D Kooperative Gesundheitsforschung in der Region Augsburg (KORA) Germany 97 90 European GoT2D UK Type 2 Diabetes Genetics Consortium (UKT2D) UK 322 320 European GoT2D Malmo-Botnia Study Finland, Sweden 478 443 European LuCamp Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (LuCamp) Denmark 997 997 European ESP Exome Sequencing Project (ESP) US 390 2843 European T2D-GENES Follow up study Genetics of Diabetes and Audit Research Tayside Study (GoDARTS) Scotland, UK 960 966 European T2D-GENES Follow up study Framingham Heart Study (FHS) US 396 596 Hispanic T2D-GENES Project 1 San Antonio Family Heart Study, San Antonio Family Diabetes/ Gallbladder Study, Veterans Administration Genetic Epidemiology Study, and the Investigation of Nephropathy and Diabetes Study Family Component US 272 218 Hispanic T2D-GENES Project 1 & SIGMAv2 Starr County, Texas US 1762 1738 Hispanic SIGMAv1 Mexico City Diabetes Study Mexico 281 549 Hispanic SIGMAv1 & v2 Multiethnic Cohort (MEC) US 1476 1443 Hispanic SIGMAv1 & v2 UNAM/INCMNSZ Diabetes Study (UIDS) Mexico 1998 1977 Hispanic SIGMAv1 & v2 Diabetes in Mexico Study (DMS) Mexico 1522 1546 Multi ethnic ProDIGY Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) US 3097 0 Multi ethnic ProDIGY SEARCH for Diabetes in Youth (SEARCH) US 553 0 South Asian T2D-GENES Project 1 London Life Sciences Population Study (LOLIPOP) UK (Indian Asian) 551 538 South Asian T2D-GENES Project 1 & Follow up study Singapore Indian Eye Study Singapore (Indian Asian) 1640 1478 South Asian T2D-GENES Follow up study Pakistan Risk of Myocardial Infarction Study (PROMIS) Pakistan 914 932 The SEARCH study contributed 553 cases and 0 controls to 52k T2D exome sequencing study.
Study phs001511
Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Follow-Up Study: Research Studies in Hong Kong

The ~52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2 diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by Next-generation sequencing in Multi-Ethnic Samples (T2D-GENES) Genetics of Type 2 Diabetes (GoT2D) Exome Sequencing Project (ESP) Slim Initiative in Genomic Medicine for the Americas (SIGMA) Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (LuCAMP) Progress in Diabetes Genetics in Youth (ProDIGY) This data generated from the Hong Kong cohort was part of the T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples) consortium, which is a NIDDK-funded international research consortium that seeks to identify genetic variants for type 2 diabetes (T2D) through multiethnic sequencing studies. The T2D-GENES Project is a multi-ethnic sequencing study designed to assess whether less common variants play a role in T2D risk and to assess similarities and differences in the distribution of T2D risk variants across ancestry groups. The individuals were obtained from over 20 cohorts across the 6 consortia that are listed in Table 1. The strategy was to perform deep exome sequencing of individuals, 24,991 with T2D and 24,953 controls, divided among five ancestry groups: Europeans, East Asians, South Asians, American Hispanics, and African Americans. The T2D-GENES, ProDIGY and SIGMA studies, sequencing was performed at the Broad Institute using the Agilent v2 capture reagent or Illumina Rapid Capture on Illumina HiSeq machines. Please note that while we summarize the full sample list in publications and below, two of the cohorts below are not in dbGaP, due to the samples not being consented for deposition. This includes the Kooperative Gesundheitsforschung in der Region Augsburg (KORA) study and Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (LuCamp) study. The Exome Sequencing Project (ESP) was deposited in dbGaP as part of their initial study and the phs numbers for that project can be found here: https://esp.gs.washington.edu/drupal/dbGaP_Releases. Table 1. 52,000 sample T2D Case/Control Whole Exome Sequencing Studies Ancestry Consortia Study Countries of Origin # Cases # Controls African American T2D-GENES Project 1 Jackson Heart Study US 500 526 African American T2D-GENES Project 1 Wake Forest School of Medicine Study US 518 530 African American ESP Exome Sequencing Project (ESP) US 467 1374 African American T2D-GENES Follow-Up Study BioMe Biobank Program (BioMe) US 1297 1256 East Asian T2D-GENES Project 1 Korea Association Research Project Korea 526 561 East Asian T2D-GENES Project 1 and Follow-Up Study Singapore Diabetes Cohort Study; Singapore Prospective Study Program Singapore (Chinese) 1486 1568 East Asian T2D-GENES Follow-Up Study Korea SNUH South Korea 450 475 East Asian T2D-GENES Follow-Up Study Research Studies in Hong Kong (Hong Kong) Hong Kong 493 485 European T2D-GENES Project 1 Ashkenazi US, Israel 506 352 European T2D-GENES Project 1 Metabolic Syndrome in Men Study (METSIM) Finland 484 498 European GoT2D Finland-United States Investigation of NIDDM Genetics (FUSION) Study Finland 472 476 European GoT2D Kooperative Gesundheitsforschung in der Region Augsburg (KORA) Germany 97 90 European GoT2D UK Type 2 Diabetes Genetics Consortium (UKT2D) UK 322 320 European GoT2D Malmö-Botnia Study Finland, Sweden 478 443 European LuCamp Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (LuCamp) Denmark 997 997 European ESP Exome Sequencing Project (ESP) US 390 2843 European T2D-GENES Follow-Up Study Genetics of Diabetes and Audit Research Tayside Study (GoDARTS) Scotland, UK 960 966 European T2D-GENES Follow-Up Study Framingham Heart Study (FHS) US 396 596 Hispanic T2D-GENES Project 1 San Antonio Family Heart Study, San Antonio Family Diabetes/ Gallbladder Study, Veterans Administration Genetic Epidemiology Study, and the Investigation of Nephropathy and Diabetes Study Family Component US 272 218 Hispanic T2D-GENES Project 1 and SIGMA v2 Starr County, Texas US 1762 1738 Hispanic SIGMA v1 Mexico City Diabetes Study Mexico 281 549 Hispanic SIGMA v1 and SIGMA v2 Multiethnic Cohort (MEC) US 1476 1443 Hispanic SIGMA v1 and SIGMA v2 UNAM/INCMNSZ Diabetes Study (UIDS) Mexico 1998 1977 Hispanic SIGMA v1 and SIGMA v2 Diabetes in Mexico Study (DMS) Mexico 1522 1546 Multiethnic ProDIGY Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) US 3097 0 Multiethnic ProDIGY SEARCH for Diabetes in Youth (SEARCH) US 553 0 South Asian T2D-GENES Project 1 London Life Sciences Population Study (LOLIPOP) UK (Indian Asian) 531 538 South Asian T2D-GENES Project 1 and Follow-Up Study Singapore Indian Eye Study Singapore (Indian Asian) 1640 1478 South Asian T2D-GENES Follow-Up Study Pakistan Risk of Myocardial Infarction Study (PROMIS) Pakistan 914 932 The research studies in Hong Kong contributed 493 cases and 485 controls to T2D-GENES Follow-Up study.
Study phs001504
Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples (T2D-GENES) Follow-Up Study: BioMe Biobank Program

The ~52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2 diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from: Type 2 Diabetes Genetic Exploration by Next-generation sequencing in Multi-Ethnic Samples (T2D-GENES) Genetics of Type 2 Diabetes (GoT2D) Exome Sequencing Project (ESP) Slim Initiative in Genomic Medicine for the Americas (SIGMA) Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (LuCAMP) Progress in Diabetes Genetics in Youth (ProDIGY) This data generated from the BioMe Biobank cohort was part of the T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples) consortium, which is a NIDDK-funded international research consortium that seeks to identify genetic variants for type 2 diabetes (T2D) through multiethnic sequencing studies. The T2D-GENES Project is a multi-ethnic sequencing study designed to assess whether less common variants play a role in T2D risk and to assess similarities and differences in the distribution of T2D risk variants across ancestry groups. The individuals were obtained from over 20 cohorts across the 6 consortia that are listed in Table 1. The strategy was to perform deep exome sequencing of individuals, 24,991 with T2D and 24,953 controls, divided among five ancestry groups: Europeans, East Asians, South Asians, American Hispanics, and African Americans. The T2D-GENES, ProDIGY and SIGMA studies, sequencing was performed at the Broad Institute using the Agilent v2 capture reagent or Illumina Rapid Capture on Illumina HiSeq machines. Please note that while we summarize the full sample list in publications and below, two of the cohorts below are not in dbGAP, due to the samples not being consented for deposition. This includes the Kooperative Gesundheitsforschung in der Region Augsburg (KORA) study and Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (LuCamp) study. The Exome Sequencing Project (ESP) was deposited in dbGAP as part of their initial study and the phs numbers for that project can be found here: https://esp.gs.washington.edu/drupal/dbGaP_Releases. Table 1. 52,000 sample T2D Case/Control Whole Exome Sequencing Studies Ancestry Consortia Study Countries of Origin # Cases # Controls African American T2D-GENES Project 1 Jackson Heart Study US 502 527 African American T2D-GENES Project 1 Wake Forest School of Medicine Study US 518 532 African American ESP Exome Sequencing Project (ESP) US 467 1374 African American T2D-GENES Follow-Up Study BioMe Biobank Program (BioMe) US 1294 1254 East Asian T2D-GENES Project 1 Korea Association Research Project Korea 526 561 East Asian T2D-GENES Project 1 and Follow-Up Study Singapore Diabetes Cohort Study; Singapore Prospective Study Program Singapore (Chinese) 1486 1568 East Asian T2D-GENES Follow-Up Study Korea SNUH South Korea 450 475 East Asian T2D-GENES Follow-Up Study Research Studies in Hong Kong (Hong Kong) Hong Kong 493 485 European T2D-GENES Project 1 Ashkenazi US, Israel 506 355 European T2D-GENES Project 1 Metabolic Syndrome in Men Study (METSIM) Finland 484 498 European GoT2D Finland-United States Investigation of NIDDM Genetics (FUSION) Study Finland 472 476 European GoT2D Kooperative Gesundheitsforschung in der Region Augsburg (KORA) Germany 97 90 European GoT2D UK Type 2 Diabetes Genetics Consortium (UKT2D) UK 322 320 European GoT2D Malmö-Botnia Study Finland, Sweden 478 443 European LuCamp Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (LuCamp) Denmark 997 997 European ESP Exome Sequencing Project (ESP) US 390 2843 European T2D-GENES Follow-Up Study Genetics of Diabetes and Audit Research Tayside Study (GoDARTS) Scotland, UK 960 966 European T2D-GENES Follow-Up Study Framingham Heart Study (FHS) US 396 596 Hispanic T2D-GENES Project 1 San Antonio Family Heart Study, San Antonio Family Diabetes/ Gallbladder Study, Veterans Administration Genetic Epidemiology Study, and the Investigation of Nephropathy and Diabetes Study Family Component US 272 218 Hispanic T2D-GENES Project 1 and SIGMA v2 Starr County, Texas US 1762 1738 Hispanic SIGMA v1 Mexico City Diabetes Study Mexico 281 549 Hispanic SIGMA v1 and SIGMA v2 Multiethnic Cohort (MEC) US 1476 1443 Hispanic SIGMA v1 and SIGMA v2 UNAM/INCMNSZ Diabetes Study (UIDS) Mexico 1998 1977 Hispanic SIGMA v1 and SIGMA v2 Diabetes in Mexico Study (DMS) Mexico 1522 1546 Multiethnic ProDIGY Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) US 3097 0 Multiethnic ProDIGY SEARCH for Diabetes in Youth (SEARCH) US 553 0 South Asian T2D-GENES Project 1 London Life Sciences Population Study (LOLIPOP) UK (Indian Asian) 531 538 South Asian T2D-GENES Project 1 and Follow-Up Study Singapore Indian Eye Study Singapore (Indian Asian) 1640 1478 South Asian T2D-GENES Follow-Up Study Pakistan Genomic Resource (PGR) Pakistan 914 932 The BioMe Biobank study contributed 1294 cases and 1254 controls to T2D-GENES Follow-Up Study.
Study phs001490

10 25 50 100 records per page

First Previous ... 7 8 9 10 11 ... Next Last

DISCOVERY

Studies
Datasets
DACs

TOOLS

Submitter Portal
DAC Portal
All Tools

CONNECT WITH US

Blog
Twitter
LinkedIn
Youtube

The European Genome-phenome Archive (EGA) is part of the ELIXIR infrastructure.

EGA is an Elixir Core Data Resource. Learn more...

ABOUT THE EGA
ABOUT THE CRG
ABOUT EMBL-EBI
CONTACT US
LEGAL NOTICE
PRIVACY NOTICE
SUPPORT

This website requires cookies, and the limited processing of your personal data in order to function.

By using the site you are agreeing to this as outlined in our Privacy Notice and Terms of Use

© Copyright 2026. EGA CONSORTIUM